Search and Filter
Results per Page:
Fred Hutch researchers receive prestigious R01 awards
NIH-funded awards will support multi-year investigations into HIV reservoirs, biomarkers of vaccine efficacy and how PrEP influences antibody pharmacokinetics
Dr. Elizabeth Halloran, expert in vaccine trial design and quantitative methods for infectious diseases, transitions to emerita
Infectious disease modeling pioneer helped outline modern precepts for design and analysis of vaccine trials, causal inference with interference; shaped a generation of infectious disease scientists
The benefits of HIV research? Let us count the ways
HIV work has helped shape the FDA, provided drugs for other infections, changed health systems globally and more, say Fred Hutch experts
When donors go all in, the magic begins
Aldarra Foundation achieved maximum impact at Fred Hutch and beyond by giving boldly, with purpose and on a timeline
Kuni Foundation awards $7M to drive adult oncology research forward
Vancouver, Washington-based foundation supports innovative early-stage research on new potential therapies
Dr. Peter Gilbert receives Marvin Zelen Leadership Award in Statistical Science
Award recognizes leadership in HIV vaccine trial development, analysis
Managing mountains of genomic data
Tools invented at Fred Hutch are helping researchers analyze the enormous global database of genomic sequences of the virus that causes COVID-19 to better understand how pathogens evolve and spread
Starting the year smarter
How patients, providers, researchers and others stay informed amid a deluge of data and information
Crunching the numbers for next-gen COVID-19 vaccines
BARDA taps Fred Hutch biostatisticians to assess new vaccine technology, more nimble trial design
Getting a paw up in the cat-and-mouse game with the COVID-19 virus
Fred Hutch researchers invent method to quickly and safely test thousands of mutations to predict which ones could help the virus escape our defenses
New biomarker could one day help tailor immunotherapy for Merkel cell carcinoma
Helps explain why only certain MCC patients respond to immune checkpoint inhibitors, could point toward new strategies to improve treatment responses
On World AIDS Day, a broad view of continuing work
Teams of Fred Hutch scientists test vaccines, treatments, new strategies
Latest Fred Hutch research on COVID-19
How Hutch scientists have been tackling coronavirus in lab and clinic
Team of top researchers prepares for endemic COVID-19
$15M Howard Hughes Medical Institute grant shared by 8 scientists at Fred Hutch and UW
What Hutch coronavirus experts are saying about omicron
Some answers, but many questions, about highly mutated new variant of COVID-19 virus
Hopes and predictions for 2022
Hutch researchers look ahead to an increase in cancer screening, improved vaccines and greater trust in science
Highlights of Fred Hutch science in 2021
From COVID-19 to cancer, Hutch scientists pursued new ideas to save lives
Science Says: Fearless science
Immunotherapy, equity in colorectal cancer and the latest on the COVID-19 virus's omicron variant
Researchers pinpoint 'correlates of protection' for Moderna vaccine
Findings may make it easier to test COVID-19 vaccine updates to protect against variants
Fred Hutch scientist Dr. Trevor Bedford receives MacArthur Fellowship
Recognized for research and public health contributions in tracking viral spread and evolution